Shares of Teva Pharmaceutical fell 5.55% to $10.21 at 14:58 EST on Tuesday, after three sequential sessions in a row of gains. NYSE Composite is sliding 0.53% to $16,238.10, following the last session’s upward trend, This seems, up until now, a somewhat negative trend trading session today.
Teva Pharmaceutical’s last close was $10.81, 30.26% below its 52-week high of $13.30.
The company’s growth estimates for the present quarter and the next is 7.3% and 13.8%, respectively.
Teva Pharmaceutical’s Revenue
Year-on-year quarterly revenue growth declined by 8.6%, now sitting on 16.28B for the twelve trailing months.
Teva Pharmaceutical’s Stock Yearly Top and Bottom Value
Teva Pharmaceutical’s stock is valued at $10.21 at 14:58 EST, way below its 52-week high of $13.30 and way above its 52-week low of $8.44.
Teva Pharmaceutical’s Moving Average
Teva Pharmaceutical’s value is below its 50-day moving average of $11.13 and under its 200-day moving average of $10.40.
More news about Teva Pharmaceutical.